Growing Capabilities: The Bridge Between Life-Changing Therapies And Patients

Through the acquisition of LSNE, we have expanded our breadth of services as a global CDMO, building on our expertise in specialty manufacturing, clinical trial supply and pharmaceutical packaging. PCI is now able to offer integrated large and small molecule solutions for its clinical and commercial clients, including global manufacturing capabilities in complex formulations, high potency, sterile fill-finish, and lyophilization, an important manufacturing process commonly used with injectable and biologic therapies. Driving development and connecting commercialization, we truly are your bridge between life-changing therapies and patients.